Cargando…

Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies

Essential thrombocythemia (ET) is a clonal stem cell disease characterized by isolated thrombocytosis and thrombohemorrhagic complications. We describe an unusual case of ET primarly presenting with skin symptoms including erythromelalgia and livedo reticularis (racemosa-type). Persistent thrombocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambichler, Thilo, Matip, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346916/
https://www.ncbi.nlm.nih.gov/pubmed/22577276
http://dx.doi.org/10.5021/ad.2012.24.2.214
_version_ 1782232244351401984
author Gambichler, Thilo
Matip, Rebecca
author_facet Gambichler, Thilo
Matip, Rebecca
author_sort Gambichler, Thilo
collection PubMed
description Essential thrombocythemia (ET) is a clonal stem cell disease characterized by isolated thrombocytosis and thrombohemorrhagic complications. We describe an unusual case of ET primarly presenting with skin symptoms including erythromelalgia and livedo reticularis (racemosa-type). Persistent thrombocytosis, bone marrow findings, JAK2 gene mutation, and markedly decreased ristocetin-cofactor activity were consistent with the diagnosis of ET and acquired von Willebrand disease. Elevated antiphospholipid antibodies were also found. The present case highlights the complex nature and diagnostic challenge of myeloproliferative disorders such as ET, which can involve multiple organ systems and often shows a variety of microvascular complications, coagulation anomalies, and autoimmune phenomena.
format Online
Article
Text
id pubmed-3346916
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-33469162012-05-10 Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies Gambichler, Thilo Matip, Rebecca Ann Dermatol Case Report Essential thrombocythemia (ET) is a clonal stem cell disease characterized by isolated thrombocytosis and thrombohemorrhagic complications. We describe an unusual case of ET primarly presenting with skin symptoms including erythromelalgia and livedo reticularis (racemosa-type). Persistent thrombocytosis, bone marrow findings, JAK2 gene mutation, and markedly decreased ristocetin-cofactor activity were consistent with the diagnosis of ET and acquired von Willebrand disease. Elevated antiphospholipid antibodies were also found. The present case highlights the complex nature and diagnostic challenge of myeloproliferative disorders such as ET, which can involve multiple organ systems and often shows a variety of microvascular complications, coagulation anomalies, and autoimmune phenomena. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012-05 2012-04-26 /pmc/articles/PMC3346916/ /pubmed/22577276 http://dx.doi.org/10.5021/ad.2012.24.2.214 Text en Copyright © 2012 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gambichler, Thilo
Matip, Rebecca
Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title_full Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title_fullStr Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title_full_unstemmed Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title_short Erythromelalgia and Livedo Reticularis in a Patient with Essential Thrombocythemia, Acquired von Willebrand Disease, and Elevated Anti-Phospholipid Antibodies
title_sort erythromelalgia and livedo reticularis in a patient with essential thrombocythemia, acquired von willebrand disease, and elevated anti-phospholipid antibodies
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346916/
https://www.ncbi.nlm.nih.gov/pubmed/22577276
http://dx.doi.org/10.5021/ad.2012.24.2.214
work_keys_str_mv AT gambichlerthilo erythromelalgiaandlivedoreticularisinapatientwithessentialthrombocythemiaacquiredvonwillebranddiseaseandelevatedantiphospholipidantibodies
AT matiprebecca erythromelalgiaandlivedoreticularisinapatientwithessentialthrombocythemiaacquiredvonwillebranddiseaseandelevatedantiphospholipidantibodies